DOUGLAS C. SLAIN, Pharm.D., BCPS, FASHP, FCCP (firstname.lastname@example.org), is a Professor and Infectious Diseases Clinical Specialist at West Virginia University and the WVU Medicine Hospitals and Clinics. Dr. Slain is also the current Chair of the Clinical Pharmacy Department. He received his B.S. Pharmacy degree and his Pharm.D. degree from Duquesne University in Pittsburgh. He completed a residency and fellowship in infectious diseases pharmacotherapy at the Medical College of Virginia Hospital (Virginia Commonwealth University) in Richmond. Dr. Slain has the distinction of being a Board Certified Pharmacotherapy Specialist (BCPS) with added qualifications in infectious diseases. Dr. Slain’s clinical practice sites at WVU include the Infectious Diseases Consult Service and the outpatient infectious diseases clinic. His research interests include antimicrobial stewardship, surgical prophylactic antimicrobial use, international antimicrobial usage, and systemic antifungal therapies. Dr. Slain is also a PGY-2 infectious diseases Residency Program Director.
It is an honor to be nominated for this position. If elected, I look forward to serving the members of the Section of the Clinical Specialists and Scientists (SCSS). I previously served as a member of the SCSS Executive Committee as a Director-at-Large, so I have a great understanding of what is required to serve as a “lead member” of this Section. In the Chair’s role, I will work with the other elected officers to provide guidance to ASHP on ways to better meet the day-to-day needs of members. Most of the Section’s activities are focused on best practices, education and training, professional development, advocacy, and policy development. I have been an active member of ASHP for over 20 years, and I believe that I am well-suited to address all of these areas. My past and current work experiences give me a great understanding of the perspectives and interests of the Section’s membership. In my current position at WVU, I work as a clinical specialist, an educator, and I am engaged in clinical practice-related research. I have also been engaged with ASHP as a state delegate, a council member, and as a member of several committees.
We will be especially challenged during this COVID era to conduct our ASHP-related activities, but I believe in the mantra “challenges = opportunities”. I look to the members of the SCSS to share their concerns, expertise, and novel ideas during this unprecedented time for the betterment of our noble profession.